{"id":"W7108456815","doi":"10.1182/blood-2025-3443","title":"ALIDHE: An ongoing open-label phase 3b study investigating ivosidenib with azacitidine in clinical practice in adult patients with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (IC)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"FPInnovations; University of Toronto; Western University","funders":"","keywords":"Azacitidine; Phases of clinical research; Adverse effect; Clinical endpoint; Myeloid leukemia; Clinical trial; Refractory (planetary science); Isocitrate dehydrogenase; Clinical Practice","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002878858,0.0009440783,0.001603058,0.0003740735,0.000481849,0.001705029,0.001172385,0.001469797,0.006068944],"category_scores_gemma":[0.001591906,0.0004632788,0.001247111,0.0005199185,0.00109471,0.001004919,0.0006647412,0.00418858,0.001154531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001069946,"about_ca_system_score_gemma":0.002627337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009154995,"about_ca_topic_score_gemma":0.002568381,"domain_scores_codex":[0.99902,0.000565102,0.00005370755,0.0001314348,0.00008657891,0.0001431976],"domain_scores_gemma":[0.9986172,0.0002410617,0.0002732652,0.0001247148,0.00009186206,0.0006519288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.680078,0.1258992,0.01124198,0.001506463,0.001503687,0.0002468474,0.000429704,0.001840798,0.03354197,0.0007440131,0.008389652,0.1345777],"study_design_scores_gemma":[0.5778032,0.395394,0.01217736,0.0001016315,0.0004569415,0.0002862189,0.0001315044,0.0007332315,0.003319234,0.000381565,0.009175216,0.0000399474],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9658246,0.004669776,0.001528353,0.001604134,0.0003041713,0.01221977,0.006094583,0.0002083143,0.00754617],"genre_scores_gemma":[0.965405,0.002896999,0.00709747,0.003059861,0.0002622896,0.009013705,0.008065022,0.00005995158,0.004139747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006068944,"threshold_uncertainty_score":0.02030265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04281600314779762,"score_gpt":0.3916544753235229,"score_spread":0.3488384721757253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}